ALNY vs VRTX: Which Stock is Better?

Side-by-side comparison of Alnylam Pharmaceuticals Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

ALNY

Alnylam Pharmaceuticals Inc

$333.39

VRTX

Vertex Pharmaceuticals Inc

$441.70

Key Metrics Comparison

MetricALNYVRTXWinner
Market Cap$45.01B$113.01BVRTX
P/E Ratio145.0528.98VRTX
EPS (TTM)$2.34$15.33VRTX
Revenue Growth0.8%0.1%ALNY
Gross Margin81.6%53.7%ALNY

Analyze ALNY

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ALNY or VRTX a better investment?

Comparing ALNY and VRTX: Alnylam Pharmaceuticals Inc has a market cap of $45.01B while Vertex Pharmaceuticals Inc has $113.01B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ALNY and VRTX?

ALNY (Alnylam Pharmaceuticals Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ALNY or VRTX?

Based on P/E ratios, VRTX trades at a lower multiple (29.0x vs 145.0x).

Which is growing faster: ALNY or VRTX?

ALNY has higher revenue growth at 0.8% vs 0.1% for VRTX.

Which company is more profitable: ALNY or VRTX?

Alnylam Pharmaceuticals Inc (ALNY) has higher gross margins at 81.6% compared to 53.7% for VRTX.

Which is the larger company: ALNY or VRTX?

Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $113.01B compared to $45.01B for ALNY.

Should I buy ALNY or VRTX in 2026?

Both ALNY and VRTX have investment merit. ALNY trades at $333.39 while VRTX trades at $441.70. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ALNY and VRTX stock?

Key differences: Market Cap ($45.01B vs $113.01B), P/E Ratio (145.0x vs 29.0x), Revenue Growth (0.8% vs 0.1%), Gross Margin (81.6% vs 53.7%).

Popular Stock Comparisons